Parkman Healthcare Partners’s Zimmer Biomet ZBH Stock Holding History

Parkman Healthcare Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20M	Sell	232,557 -37,000	-14%	-$3.24M	2.05%	16
2026 Q1	$24.4M	Buy	269,557 +118,508	+78%	+$10.9M	2.51%	12
2025 Q4	$13.6M	Sell	151,049 -100,371	-40%	-$9.52M	1.29%	26
2025 Q3	$24.8M	Buy	251,420 +11,025	+5%	+$1.09M	2.58%	8
2025 Q2	$21.9M	Buy	240,395 +39,895	+20%	+$3.86M	2.52%	9
2025 Q1	$22.7M	Buy	+200,500	New	+$21.4M	2.69%	11
2023 Q4	–	Sell	-71,000	Closed	-$7.97M	–	106
2023 Q3	$7.97M	Buy	+71,000	New	+$9.02M	1.46%	21
2023 Q2	–	Sell	-65,000	Closed	-$8.4M	–	104
2023 Q1	$8.4M	Buy	+65,000	New	+$8.16M	1.83%	22
2020 Q1	–	Sell	-97,850	Closed	-$14.2M	–	78
2019 Q4	$14.2M	Buy	+97,850	New	+$13.5M	4.11%	3

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Parkman Healthcare Partners's ZBH Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its Zimmer Biomet (ZBH) stake by 14% in Q2 2026, selling an estimated $3.24M and leaving 232,557 shares worth $20M. The position accounts for 2.05% of the portfolio, ranked #16.

Parkman Healthcare Partners first reported a position in ZBH in Q4 2019 and has held it in 9 quarters since. The position peaked at $24.8M in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Parkman Healthcare Partners held 232,557 shares of Zimmer Biomet worth $20M as of Q2 2026.
Parkman Healthcare Partners sold 37,000 Zimmer Biomet shares in Q2 2026, an estimated $3.24M.
Zimmer Biomet made up 2.05% of Parkman Healthcare Partners's portfolio in Q2 2026, its #16 holding.
Parkman Healthcare Partners first reported a position in Zimmer Biomet in Q4 2019 and has held it in 9 quarters since.
Parkman Healthcare Partners's Zimmer Biomet position peaked at $24.8M in Q3 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.